Fracture prevalence among human immunodeficiency virus (HIV)-infected versus non-HIV-infected patients in a large U.S. healthcare system - PubMed (original) (raw)

Comparative Study

. 2008 Sep;93(9):3499-504.

doi: 10.1210/jc.2008-0828. Epub 2008 Jul 1.

Affiliations

Comparative Study

Fracture prevalence among human immunodeficiency virus (HIV)-infected versus non-HIV-infected patients in a large U.S. healthcare system

Virginia A Triant et al. J Clin Endocrinol Metab. 2008 Sep.

Abstract

Context: Reduced bone mineral density has been demonstrated among HIV-infected patients, but fracture prevalence is unknown.

Objective: The objective of the study was to compare fracture prevalence in HIV-infected and non-HIV-infected patients.

Design: This was a population-based study.

Setting: The study was conducted at a large U.S. health care system.

Patients: A total of 8525 HIV-infected and 2,208,792 non-HIV-infected patients with at least one inpatient or outpatient encounter between October 1, 1996, and March 21, 2008, was compared.

Main outcome measure: Fracture prevalence using specific International Classification of Diseases, Ninth Revision, Clinical Modification fracture codes was measured.

Results: The overall fracture prevalence was 2.87 vs. 1.77 patients with fractures per 100 persons in HIV-infected, compared with non-HIV-infected patients (P < 0.0001). Among females, the overall fracture prevalence was 2.49 vs. 1.72 per 100 persons in HIV-infected vs. non-HIV-infected patients (P = 0.002). HIV-infected females had a higher prevalence of vertebral (0.81 vs. 0.45; P = 0.01) and wrist (1.31 vs. 0.83; P = 0.01) fractures per 100 persons, compared with non-HIV-infected females but had a similar prevalence of hip fractures (0.47 vs. 0.56; P = 0.53). Among males, the fracture prevalence per 100 persons was higher in HIV-infected vs. non-HIV-infected patients for any fracture (3.08 vs. 1.83; P < 0.0001), vertebral fractures (1.03 vs. 0.49; P < 0.0001), hip fractures (0.79 vs. 0.45; P = 0.001), and wrist fractures (1.46 vs. 0.99; P = 0.001). Fracture prevalence was higher relative to non-HIV-infected patients among African-American and Caucasian females and Caucasian males.

Conclusions: Fracture prevalence is increased in HIV-infected compared with non-HIV-infected patients.

PubMed Disclaimer

Figures

Figure 1

Figure 1

Fracture prevalence comparing HIV-infected and non-HIV-infected patients by gender and site of fracture, age group, and race. Panels A, C, and E represent females. Panels B, D, and F represent males. A and B, Comparison of fracture prevalence in HIV-infected vs. non-HIV-infected patients according to gender and site of fracture. C and D, Comparison of fracture prevalence in HIV-infected vs. non-HIV-infected patients according to gender and age group. E and F, Comparison of fracture prevalence in HIV-infected vs. non-HIV-infected patients according to gender and race. Light bars and lines represent HIV-infected patients; dark bars and lines represent non-HIV-infected patients. In C and D, the P values are for the comparison of overall fracture prevalence between HIV-infected and non-HIV-infected patients.

References

    1. Tebas P, Powderly WG, Claxton S, Marin D, Tantisiriwat W, Teitelbaum SL, Yarasheski KE 2000 Accelerated bone mineral loss in HIV-infected patients receiving potent antiretroviral therapy. AIDS 14:F63–F67 - PMC - PubMed
    1. Carr A, Miller J, Eisman JA, Cooper DA 2001 Osteopenia in HIV-infected men: association with asymptomatic lactic acidemia and lower weight pre-antiretroviral therapy. AIDS 15:703–709 - PubMed
    1. Gold J, Pocock N, Li Y 2002 Bone mineral density abnormalities in patients with HIV infection. J Acquir Immune Defic Syndr 30:131–132 - PubMed
    1. Mondy K, Yarasheski K, Powderly WG, Whyte M, Claxton S, DeMarco D, Hoffmann M, Tebas P 2003 Longitudinal evolution of bone mineral density and bone markers in human immunodeficiency virus-infected individuals. Clin Infect Dis 36:482–490 - PubMed
    1. Bongiovanni M, Fausto A, Cicconi P, Menicagli L, Melzi S, Ligabo VE, Cornalba G, Bini T, Sardanelli F, Monforte AD 2005 Osteoporosis in HIV-infected subjects: a combined effect of highly active antiretroviral therapy and HIV itself? J Acquir Immune Defic Syndr 40:503–504 - PubMed

Publication types

MeSH terms

Grants and funding

LinkOut - more resources